ChemInform Abstract: Synthetic Inhibitors of Cell Adhesion: A Glycopeptide from E-Selectin Ligand 1 (ESL-1) with the Arabino Sialyl Lewisx Structure.

ChemInform ◽  
2010 ◽  
Vol 33 (4) ◽  
pp. no-no
Author(s):  
Markus Roesch ◽  
Holger Herzner ◽  
Wolfgang Dippold ◽  
Martin Wild ◽  
Dietmar Vestweber ◽  
...  
ChemInform ◽  
2007 ◽  
Vol 38 (22) ◽  
Author(s):  
Christian Filser ◽  
Danuta Kowalczyk ◽  
Claire Jones ◽  
Martin K. Wild ◽  
Ute Ipe ◽  
...  

Author(s):  
Markus Rösch ◽  
Holger Herzner ◽  
Wolfgang Dippold ◽  
Martin Wild ◽  
Dietmar Vestweber ◽  
...  

2007 ◽  
Vol 46 (12) ◽  
pp. 2108-2111 ◽  
Author(s):  
Christian Filser ◽  
Danuta Kowalczyk ◽  
Claire Jones ◽  
Martin K. Wild ◽  
Ute Ipe ◽  
...  

2016 ◽  
Vol 470 (2) ◽  
pp. 425-430 ◽  
Author(s):  
Hiroyasu Yamamoto ◽  
Nana Kuroda ◽  
Hiromi Uekita ◽  
Ikoi Kochi ◽  
Akane Matsumoto ◽  
...  

2020 ◽  
Vol 29 ◽  
pp. 096368972091270
Author(s):  
Pierre Edouard Dollet ◽  
Mei Ju Hsu ◽  
Jérôme Ambroise ◽  
Milena Rozzi ◽  
Joachim Ravau ◽  
...  

Adult-derived human liver stem/progenitor cells (ADHLSCs) are a promising alternative to orthotopic liver transplantation in the treatment of inborn errors of metabolism. However, as is the case with many mesenchymal stromal cells, ADHLSCs have shown a low level of engraftment, which could be explained by the fact that they lack expression of selectin ligand and LFA-1 and only slightly express VLA- 4, molecules that have been shown to be involved in cell adhesion to the endothelium. In this paper, we have investigated strategies to increase their rolling and adhesion during the homing process by (1) adding a selectin ligand (Sialyl Lewis X) to their surface using biotinyl- N-hydroxy-succinimide–streptavidin bridges, and (2) protecting the adhesion proteins from trypsinization-induced damage using a thermosensitive polymer for cell culture and a nonenzymatic cell dissociation solution (CDS) for harvest. Despite increasing adhesion of ADHLSCs to E-selectin during an adhesion test in vitro performed under shear stress, the addition of Sialyl Lewis X did not increase adhesion to endothelial cells under the same conditions. Cultivating cells on a thermosensitive polymer and harvesting them with CDS increased their adhesion to endothelial cells under noninflammatory conditions, compared to the use of trypsin. However, we were not able to demonstrate any improvement in cell adhesion to the endothelium following culture on polymer and harvest with CDS, suggesting that alternative methods of improving engraftment still need to be evaluated.


Blood ◽  
1999 ◽  
Vol 94 (3) ◽  
pp. 884-894 ◽  
Author(s):  
Horace M. DeLisser ◽  
Melpo Christofidou-Solomidou ◽  
Jing Sun ◽  
Marian T. Nakada ◽  
Kathleen E. Sullivan

Neutrophil accumulation at sites of inflammation is mediated by specific groups of cell adhesion molecules including the β2 (CD18) integrins on leukocytes and the selectins (P- and E-selectin on the endothelium and L-selectin on the leukocyte). This is supported by studies of patients with leukocyte adhesion deficiency syndromes whose leukocytes are genetically deficient in the expression of β2 integrins or selectin carbohydrate ligands (eg, sialyl-Lewisx). However, inherited deficiency or dysfunction of endothelial cell adhesion molecules involved in leukocyte recruitment has not been previously described. In this report we describe a child with recurrent infections and clinical evidence of impaired pus formation reminiscent of a leukocyte adhesion deficiency syndrome, but whose neutrophils were functionally normal and expressed normal levels of CD18, L-selectin, and sialyl-Lewisx. In contrast, immunohistochemical staining of inflamed tissue from the patient showed the absence of E-selectin from the endothelium, although E-selectin mRNA was present. However, E-selectin protein was expressed as significantly elevated levels of circulating soluble E-selectin were detected, the molecular size of which was consistent with a proteolytically cleaved form of E-selectin. Gene sequencing failed to show evidence of a secreted mutant variant. These data represent, to our knowledge, the first description of a potentially inherited dysfunction of an endothelial cell adhesion molecule involved in leukocyte recruitment and provide additional human evidence of the importance of endothelial selectins in the inflammatory response.


Immunity ◽  
1999 ◽  
Vol 11 (1) ◽  
pp. 79-89 ◽  
Author(s):  
Nobuyoshi Hiraoka ◽  
Bronislawa Petryniak ◽  
Jun Nakayama ◽  
Shigeru Tsuboi ◽  
Misa Suzuki ◽  
...  

2004 ◽  
Vol 295 (2) ◽  
pp. 549-554 ◽  
Author(s):  
Rüdiger Horstkorte ◽  
Kirstin Rau ◽  
Werner Reutter ◽  
Sabine Nöhring ◽  
Lothar Lucka

2018 ◽  
Vol 118 (12) ◽  
pp. 2134-2144
Author(s):  
Ruchira Engel ◽  
Laura Delvasto-Nuñez ◽  
Dorina Roem ◽  
Gerard van Mierlo ◽  
Stephanie Holst ◽  
...  

Background C1-inhibitor (C1-inh) therapeutics can reduce neutrophil activity in various inflammatory conditions. This ‘novel’ anti-inflammatory effect of C1-inh is attributed to the tetrasaccharide sialyl LewisX (SLeX) present on its N-glycans. Via SLeX, C1-inh is suggested to interact with selectins on inflamed endothelium and prevent neutrophil rolling. However, C1-inh products contain plasma glycoprotein α1-antichymotrypsin (ACT) as a co-purified protein impurity. Objective This article investigates the contribution of ACT to the effects observed with C1-inh. Materials and Methods We have separated C1-inh and ACT from a therapeutic C1-inh preparation and investigated the influence of these proteins on SLeX–selectin interactions in a specific in vitro model, which makes use of rolling of SLeX-coated beads on immobilized E-selectin. Results We find that ACT and not C1-inh, shows a clear sialic acid-dependent interference in SLeX–selectin interactions, at concentrations present in C1-inh therapeutics. Furthermore, we do not find any evidence of SLeX on C1-inh using either Western blotting with anti-SLeX antibodies (CSLEX1 and KM93) or by mass spectrometric analysis of N-glycans. C1-inh reacts weakly to antibody HECA-452, which detects a broad range of selectin ligands, but ACT gives a much stronger signal, suggesting the presence of a selectin ligand on ACT. Conclusion The ‘novel’ anti-inflammatory effects of C1-inh are unlikely due to SLeX on C1-inh and can in fact be due to SLeX-like glycans on ACT, present in C1-inh products. In view of our results, it is important to assess the role of ACT in vivo and revisit past studies performed with commercial C1-inh.


Sign in / Sign up

Export Citation Format

Share Document